Impact China III: Pharmaceutical R&D Global Summit

Venue: Renaissance Shanghai Pudong Hotel

Location: Shanghai, China

Event Date/Time: May 20, 2007 End Date/Time: May 23, 2007
Report as Spam


The growing impact that China is having on the global pharmaceutical marketplace is currently being felt by the industry on a wide scale in areas such as outsourcing, clinical trials, manufacturing and more recently, drug discovery and development. But what should the industry realistically expect from their investments in China in the coming years?

Impact China III will separate the hype vs. reality surrounding the Chinese market by providing attendees an unbiased look into the current state of the industry.

This is the best conference on China in 2007. Over 300 industry executives representing over 100 companies and 10 different countries attended the inaugural meeting last May in Beijing.

Over 75 speakers will give their “on-the-ground” views addressing timely and pressing issues including:

A Comparison of China vs. India, Japan, Asia-Pacific
Intellectual Property & Patent Protection/Enforcement
Venture Capital Investment, Technology Valuation/Transfer, East/West M&A’s
The Emerging Drug Discovery Landscape in China
Outsourcing Preclinical & Clinical R&D to China
Manufacturing, APIs and Generics in China
Regulatory Insights in Clinical Trials, GMPs and Drugs/Biologics
Business Practices, Commercialization and Marketing Strategies in the Chinese Market
East/West Partnerships, Licensing, and Business Development Strategies


100 Changlie Road